We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSubconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial.AuthorsPetsoglou, Constantinos; Balaggan, Kamaljit S; Dart, John K G; Bunce, Catey; Xing, Wen; Ali, Robin R; Tuft, Stephen JAbstractTo evaluate the off-label use of subconjunctival bevacizumab for corneal neovascularisation (CoNV).PublicationThe British journal of ophthalmology, 2013, Vol 97, Issue 1, p28ISSN1468-2079Publication typeJournal ArticleDOI10.1136/bjophthalmol-2012-302137